Simble surpasses $1 million in orders for SimbleSense

|

Published 12-OCT-2018 11:01 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Simble Solutions Limited (ASX:SIS) has informed the market this morning that it has accrued over $1 million in orders across Australia and the UK for the Simble Energy Platform (or ‘SimbleSense’).

SIS, which is the fastest growing Software as a Service (SaaS) company on the ASX, continues to deliver promising early results after securing its first large scale channel partners six months ago.

SimbleSense is an IoT supported real-time software solution that enables businesses to adjust, remotely control and monetise their energy systems. The platform represents a new revenue stream for SIS, with each installation generating recurring SaaS revenue recognised on a pro rata basis over the user’s contract life.

Synnex Australia, which is the company’s primary distributor in Australia, has placed its second material order for the SimbleSense bundle to cover projected sales by SIS’ partners.

This news is just the latest affirmation that SIS is continuing to execute on its growth strategy, as it looks to expand the scale of its distribution network. Discussions are now underway with Synnex reseller partners to scale the company’s channel network.

SIS CEO Fadi Geha commented on today’s news, “Passing the million dollar milestone within months of launching to our large channel partners is exciting, however it is just the beginning.

“We are scratching the surface in terms of the sales velocity these partners can achieve and look forward to ramping up activity to meet market demand.

“The momentum in the business provides a clear pathway for a significant uplift in sales active over the coming 12 months.”

Under its current configuration, the SimbleSense is a bundled software and hardware solution, with a weighted average subscription term of three years.

As subscriptions are prepaid in advance, recent growth in orders is poised to have a material impact on the company’s cash flow, with the first material impact expected during the current quarter. Associated revenue commences following installation by SIS partners with the end user.

About Simble Solutions

SIS is an Australian software company focused on energy management and mobility solutions.

The company’s SaaS platform features intuitive IoT capabilities and empowers organisations to remotely automate their energy savings and reducing their energy bill.

SIS operates in the small and medium business (SME) market, with offices in Sydney and Melbourne (Australia), London (UK), Auckland (New Zealand), Dubai (UAE) and Da Nang (Vietnam).

This information is general financial product advice only and you should consider seek professional advice before making any investment decision. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X